Generali Asset Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105K Sell
1,564
-136
-8% -$9.95K ﹤0.01% 464
2026
Q1
$130K Hold
1,700
﹤0.01% 433
2025
Q4
$109K Buy
1,700
+149
+10% +$9.18K ﹤0.01% 440
2025
Q3
$97.8K Hold
1,551
﹤0.01% 464
2025
Q2
$116K Hold
1,551
﹤0.01% 452
2025
Q1
$137K Sell
1,551
-29,038
-95% -$2.74M ﹤0.01% 439
2024
Q4
$2.79M Buy
+30,589
New +$3.14M 0.07% 265

Other funds holding EMN

Generali Asset Management's EMN Position: Q2 2026 in Review

Generali Asset Management reduced its Eastman Chemical (EMN) stake by 8% in Q2 2026, selling an estimated $9.95K and leaving 1,564 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #464.

Generali Asset Management first reported a position in EMN in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.79M in Q4 2024. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Generali Asset Management held 1,564 shares of Eastman Chemical worth $105K as of Q2 2026.
  • Generali Asset Management sold 136 Eastman Chemical shares in Q2 2026, an estimated $9.95K.
  • Eastman Chemical made up ﹤0.01% of Generali Asset Management's portfolio in Q2 2026, its #464 holding.
  • Generali Asset Management first reported a position in Eastman Chemical in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Eastman Chemical position peaked at $2.79M in Q4 2024.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.